These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25994520)

  • 1. Laryngeal spindle cell carcinoma: A population-based analysis of incidence and survival.
    Dubal PM; Marchiano E; Kam D; Dutta R; Kalyoussef E; Baredes S; Eloy JA
    Laryngoscope; 2015 Dec; 125(12):2709-14. PubMed ID: 25994520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laryngeal Verrucous Carcinoma: A Population-Based Analysis.
    Dubal PM; Svider PF; Kam D; Dutta R; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):799-805. PubMed ID: 26124268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngeal Papillary Squamous Cell Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Dutta R; Husain Q; Kam D; Dubal PM; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Jul; 153(1):54-9. PubMed ID: 25917664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laryngeal adenosquamous carcinoma: A population-based perspective.
    Dubal PM; Unsal AA; Echanique KA; Vazquez A; Reder LS; Baredes S; Eloy JA
    Laryngoscope; 2016 Apr; 126(4):858-63. PubMed ID: 26452061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subglottic Squamous Cell Carcinoma: A Population-Based Study of 889 Cases.
    Marchiano E; Patel DM; Patel TD; Patel AA; Xue YE; Eloy JA; Baredes S; Park RC
    Otolaryngol Head Neck Surg; 2016 Feb; 154(2):315-21. PubMed ID: 26607281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Impact of Initial Therapy in Patients with T1-T2 Glottic Squamous Cell Carcinoma.
    Brady JS; Marchiano E; Kam D; Baredes S; Eloy JA; Park RC
    Otolaryngol Head Neck Surg; 2016 Aug; 155(2):257-64. PubMed ID: 27026735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of the Larynx-20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and ICD-O-3 Topographic Primary Sites-Codes C32.0-9: A Systematic Review of 43,103 Cases for Diagnosis Years 1975-2017: (NCI SEER*Stat 8.3.9).
    Milano AF
    J Insur Med; 2024 Jul; 51(2):92-110. PubMed ID: 39266004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laryngeal Neuroendocrine Carcinoma: A Population-Based Analysis of Incidence and Survival.
    Ghosh R; Dutta R; Dubal PM; Park RC; Baredes S; Eloy JA
    Otolaryngol Head Neck Surg; 2015 Dec; 153(6):966-72. PubMed ID: 26183520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngeal chondrosarcoma: a population-based analysis.
    Dubal PM; Svider PF; Kanumuri VV; Patel AA; Baredes S; Eloy JA
    Laryngoscope; 2014 Aug; 124(8):1877-81. PubMed ID: 24474667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival.
    Dutta R; Dubal PM; Svider PF; Liu JK; Baredes S; Eloy JA
    Laryngoscope; 2015 Nov; 125(11):2491-7. PubMed ID: 26228792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngeal adenoid cystic carcinoma: A population-based perspective.
    Dubal PM; Svider PF; Folbe AJ; Lin HS; Park RC; Baredes S; Eloy JA
    Laryngoscope; 2015 Nov; 125(11):2485-90. PubMed ID: 26153623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival.
    Hoffman HT; Porter K; Karnell LH; Cooper JS; Weber RS; Langer CJ; Ang KK; Gay G; Stewart A; Robinson RA
    Laryngoscope; 2006 Sep; 116(9 Pt 2 Suppl 111):1-13. PubMed ID: 16946667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of T3N1 glottic carcinoma: therapeutic outcomes.
    Spector JG; Sessions DG; Lenox J; Simpson J
    Laryngoscope; 2006 Jan; 116(1):106-10. PubMed ID: 16481820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and prognostic indicators in laryngeal lymphoma: A population-based analysis.
    Hong SA; Tajudeen BA; Choi S; Husain IA
    Laryngoscope; 2018 Sep; 128(9):2044-2049. PubMed ID: 29392765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes in advanced laryngeal cancer.
    Megwalu UC; Sikora AG
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):855-60. PubMed ID: 25144163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic trends in management of early-stage laryngeal cancer.
    Mourad M; Dezube A; Moshier E; Shin E
    Laryngoscope; 2016 Apr; 126(4):880-4. PubMed ID: 26526215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.
    Zhang H; Travis LB; Chen R; Hyrien O; Milano MT; Newlands SD; Chen Y
    Cancer; 2012 Mar; 118(5):1276-87. PubMed ID: 21773970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic outcomes of laryngeal cancer at Kyoto University Hospital for 10 years.
    Tamura Y; Tanaka S; Asato R; Hirano S; Yamashita M; Tamaki H; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):62-5. PubMed ID: 17453448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.